In 2017, Cardiovascular Diseases, Heart

In 2017, Cardiovascular Diseases, Heart




ЧИТАТЬ ДАЛЕЕ ...







































In 2017, Cardiovascular Diseases, Heart

Разделы:



Описание In 2017, Cardiovascular Diseases, Heart

In 2017, Cardiovascular Diseases, Heart Kasabay nito, hindi inirerekomenda ang pangmatagalang pag-inom ng mga gamot mula sa kategoryang Diuretics, dahil ang mahahalagang sangkap tulad ng Potassium, Calcium, Magnesium ay mabilis na nailalabas sa katawan kasama ng sobrang tubig at asin. Alinsunod sa katangiang ito, sinasabayan ng mga Diuretics ang pag-inom ng mga gamot na may laman ng mga sangkap na ito. Maaaring ito ay mga vitamin at mineral na complexes, monokomponent, o mga suplemento sa pagkain na may napatunayang klinikal na bisa. Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot.

Cardiovascular disease and heart health: the state of the research in the year 2017 In 2017, cardiovascular diseases (KVE) remained the leading cause of death worldwide and in Germany. According to statistics from the Robert Koch Institute and the German heart Foundation KVE accounted for about 30% of all deaths, heart attacks, heart failure and stroke were the most common clinical manifestations. Epidemiological Trends The epidemiological data from 2017 showed a slight decrease in the incidence of acute heart attacks in persons over 65 years, which was due to the improvement of preventative measures and drug therapy. At the same time an increase in the number of heart failure cases, however, was observed in younger patients (under 55 years), and in particular in individuals with obesity, type 2 Diabetes mellitus and arterial hypertension. Risk factors Of the modifiable risk factors included in the year 2017: arterial hypertension (blood pressure≥140/90 mmHg), Hyperlipidemia (elevated levels of LDL‑cholesterol >3.0 mmol/l), Tobacco, physical inactivity, unhealthy diet, Obesity (BMI ≥30 kg/m 2 ), Diabetes mellitus. Non-modifiable risk factors included age, gender (male), and family history of early cardiovascular events. Diagnostic Progress In 2017, have been published new guidelines for the diagnosis of heart illnesses, especially on the following methods: ECG for the detection of arrhythmias and Ischemia, Echocardiography for the assessment of cardiac function and valve defects, Coronary computed tomography (CCTA) as a non‑invasive Alternative to conventional coronary angiography, Biomarkers such as high-sensitive Troponin and NT‑proBNP for the early detection of myocardial damage and heart failure. Therapeutic Approaches The treatment strategies in 2017 included: Drug Therapy: ACE inhibitor or ARB in heart failure, Beta-blockers to reduce heart rate and blood pressure monitoring, Statins for lipid-lowering, Anticoagulants (aspirin, Clopidogrel) after myocardial infarction. Interventional Procedures: Percutaneous coronary Intervention (PCI) with stent implantation, Ablation therapy for atrial fibrillation. Prevention: Regular physical activity (150 minutes/week of moderate stress), Change in diet (DASH diet, Mediterranean diet), Smoking abstinence Blood pressure and blood sugar control. Conclusion The year 2017 marked an important step in the development of prevention and treatment strategies for circuit-limiting diseases. The Integration of new diagnostic methods and evidence-based therapy concepts improved the prognosis of patients with cardiovascular diseases significantly. Nevertheless, the control of risk factors and the promotion of a healthy life style, a Central challenge for the future.





Зачем нужен In 2017, Cardiovascular Diseases, Heart

Ektrak mula sa prutas ng cranberry Ektrak mula sa prutas ng appleberry Magnesium L-Arginin Ektrak mula sa dahon at bulaklak ng hawthorn Pulbos ng bulaklak ng hibiscus Ektrak mula sa dahon ng oliba Ektrak mula sa buto ng ubas Ektrak mula sa black currant Coenzyme Q10 Bitamina B6 Folate The Sanatorium of the Ministry of internal Affairs of the heart-vascular diseases Most common diseases of the cardiovascular System

The Sanatorium of the Ministry of internal Affairs of the heart-vascular diseases

Most common diseases of the cardiovascular System

The complex of exercise therapy in cardiovascular diseases

The complex of exercise therapy in cardiovascular diseases




Мнение эксперта

Ang Cardio Balance Kapseln ay isang epektibo at ligtas na paraan para mapanatili ang kalusugan ng puso at pababain ang presyon ng dugo. Dahil sa kanilang natural na sangkap at mataas na bisa, nagiging maaasahang katuwang sila sa paglaban sa mataas na presyon ng dugo at sa pagpapabuti ng kalidad ng buhay. Отзывы о In 2017, Cardiovascular Diseases, Heart

Маргарита: Not all cases of high Blood pressure present symptoms of headaches. However, when there is a sudden surge in blood pressure, it can cause a headache. The headache feels like throbbing pain and occurs on both sides of the head. It gets worse with physical activity. (It’s also a sign of a medical emergency).




Как заказать?

Заполните форму для консультации и заказа In 2017, Cardiovascular Diseases, Heart. Оператор уточнит у вас все детали и мы отправим ваш заказ. Через 3-7 дней вы получите посылку и оплатите её при получении.

Cardiovascular Disease News. The best medicine against high blood pressure. Respiratory and cardiovascular diseases. Diet therapy in cardiovascular diseases, the list of literature. Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6.

Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot.

Osteoporosis and cardiovascular diseases

https://baikal.market/articles/13427-oil-for-high-blood-pressure.html

http://silvernz.beget.tech/articles/44101-percentage-of-cardiovascular-diseases-in-germany.html


Google
Google


Prevention of cardiovascular diseases: The role of structured conversations in the patient counseling Cardiovascular disease (CVD) is the leading cause of death and are associated with significant socio-economic costs. Effective prevention of these diseases is therefore of the highest health policy relevance. One of the key building blocks of preventive measures structured conversations between health professional and patient, with the aim of modification of risk factors. Risk factors and the need for advice Among the main risk factors for CVD: Hypertension; Hyperlipidemia; Diabetes mellitus; Tobacco consumption; physical inactivity; unhealthy diet; Overweight and obesity; chronic Stress. Many of these factors through targeted changes in behaviour can be influenced. Here the individual patient comes in counselling: Through structured interviews, patients can be informed about their individual risks, motivated and be able to establish health-promoting behaviors. Objectives and methods of preventive conversations A structured prevention conversation has several objectives: Education: imparting Knowledge about the risk factors, disease consequences and possibilities for Prevention. Motivation: to support the development of a clear Intention to change behaviour (for example, by using the Motivated interviewing, Motivational Interviewing). Planning: joint development of realistic and measurable goals and objectives (for example, I run three Times a week for 30 minutes), as well as a concrete implementation strategies. Long-term support: setting appointments for follow-up calls to Review progress and adjust the Plan. Practice Implementation: A Stage Model A successful consultancy in the following phases: Preparation: survey of the medical history, measurement of blood pressure, cholesterol, BMI, etc. Risk disclosure: presentation of the individual risk profiles (for example, with the help of the risk scale SCORE), and joint prioritization of machining factors. Target agreement: formulation of specific, time-limited goals according to the SMART principle (specific, measurable, accepted, realistic, time-bound). Implementation assistance: provision of materials (nutrition plans, exercise programs), mediation of self-control techniques (e.g., blood pressure measurement at home) and, where appropriate, referral to specialists (dieticians, physiotherapists). Follow-up: Regular checks (every 3-6 months), assessment of Successes and joint Revision of strategies, in the case of setbacks. Evidence Several studies have demonstrated the effectiveness of structured counselling sessions: A meta-analysis showed that individual counseling can help lower blood pressure by an average of 5,0/3,8 mmHg. Interventions for diet and exercise advice lead to significant improvements in blood lipids and BMI. Motivational interview techniques, the probability of a long-term change in behavior increase compared to the sole enlightenment. Conclusion Structured interviews are an essential part of the prevention of cardiovascular diseases. They allow an individual risk analysis, promote the patient's motivation and assist in the implementation of health-promoting measures. A systematic Integration of such approaches in the regular supply could make a significant contribution to the reduction of the frequency of heart attacks and strokes.
23:42
Нет комментариев. Ваш будет первым!
Посещая этот сайт, вы соглашаетесь с тем, что мы используем файлы cookie.